Sumitomo Pharma Co Ltd
TSE:4506
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Sumitomo Pharma Co Ltd
Sumitomo Pharma Co Ltd
Current Portion of Long-Term Debt
Sumitomo Pharma Co Ltd
Current Portion of Long-Term Debt Peer Comparison
4502
4568
4578
4519
4503
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sumitomo Pharma Co Ltd
TSE:4506
|
Current Portion of Long-Term Debt
¥285.5B
|
CAGR 3-Years
196%
|
CAGR 5-Years
149%
|
CAGR 10-Years
40%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Current Portion of Long-Term Debt
¥367.3B
|
CAGR 3-Years
155%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
9%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Current Portion of Long-Term Debt
¥399m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
-60%
|
CAGR 10-Years
-45%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Current Portion of Long-Term Debt
¥72B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
32%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Astellas Pharma Inc
TSE:4503
|
Current Portion of Long-Term Debt
¥472.3B
|
CAGR 3-Years
208%
|
CAGR 5-Years
306%
|
CAGR 10-Years
84%
|
See Also
What is Sumitomo Pharma Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
285.5B
JPY
Based on the financial report for Mar 31, 2024, Sumitomo Pharma Co Ltd's Current Portion of Long-Term Debt amounts to 285.5B JPY.
What is Sumitomo Pharma Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
40%
Over the last year, the Current Portion of Long-Term Debt growth was 5 762%. The average annual Current Portion of Long-Term Debt growth rates for Sumitomo Pharma Co Ltd have been 196% over the past three years , 149% over the past five years , and 40% over the past ten years .
You don't have any saved screeners yet
